Healthcare record management platform Ciitzen has received $17m in an Andreessen Horowitz-led round that included participation from Alphabet subsidiary Verily.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The respiratory disease drug developer has collected series A funding from investors including Shionogi to fund clinical trials of its lead drug candidate .

Magnitude Biosciences started operations in September 2018 to commercialise a Durham University ageing research technology centred on the C.elegans nematode worm.

The accelerator is open to medical device and healthcare tech businesses that have already amassed $500,000 of capital or are generating revenues.

The accelerator is open to medical device and healthtech businesses that have already amassed $500,000 of capital or are generating revenues.

Investors including Sanford Health and Itochu have added $9m to a series C round for the medical examination technology developer that now stands at $33.5m.

UT Austin-founded Kyn Therapeutics has been backed by Celgene in a strategic pact that also includes a $80m non-equity payment, giving Celgene the right to license two programs.

Dietary suggestion software spinout Food Genes and Me compiles personalised healthy eating tips based on uploaded DNA reports from external genetic analysis tools.

The orthopaedic diagnostics equipment developer has added $18.5m to a series C round featuring Smith & Nephew that now stands at $37.6m.